2-Methyl-5-(5-methyl-benzooxazol-2-yl)-phenylamine, 100mg

(2R)-2-{[(tert-butoxy)carbonyl]amino}non-8-enoic acid, 98%, 100mg

Methyl 3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 5g

(3S,4R)-1-tert-Butyl-4-(2,4-difluorophenyl)pyrrolidine-3-carboxylic acid, 95.0%, 250mg

4-(Chloromethyl)pyridine Hydrochloride>98.0%(HPLC)(T)25g

Methyl 4-iodopyridine-2-carboxylate, 95.0%, 1g

5-Chloro-4-fluoro-2-nitrophenol, 95.0%, 10g

(5-FLUORO-3-METHYLPYRIDIN-2-YL)METHANOL, 95%, 100mg

(S)-3-3'-Bis(3,5-dimethylphenyl)-1,1'-bi-2-naphthol, 1g

(4aS,8aR)-3,8a-Dimethyl-5-methylene-4,4a,5,6,7,8,8a,9-octahydronaphtho[2,3-b]furan, 95.0%, 50mg

Tripropilenglicole monometil etere, min 97%, per sintesi, 5 l, confezione in plastica.

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methyl-3-(tritylthio)butanoic acid, 97%, 100g

Azido-PEG11-amine, 93%, 500mg